Home
About Us
FAQ
Contact Us
Media Tools
ExpertConnect App
MyExpertNet
University Partners
Becoming a Partner
Key Organizations
Search Assistance
Help
Expert Profile
Views:
165
Share
QR code
Edit Profile
Stephen Staal
Professor
MD-HEMATOLOGY/ONCOLOGY | COLLEGE-MEDICINE
View:
Select
All (all in one)
Research Terms and Keywords
Publications
Co-Investigator Network
Websites
Contact
All
Research
Publications
Network
Websites
Contact
Research Terms & Keywords
Research Terms
Hematology
Research Projects
Ends
Title
08-2021
A Clinical Trial to Determine the Efficacy of Five Years of Letrozole Compared to Placebo in Patients Completing Five Years of Hormonal Therapy Consisting of an Aromatase Inhibitor (AI) or Tamoxifen Followed by an AI in Prolonging Disease-Free Survival i
A Clinical Trial to Determine the Efficacy of Five Years of Letrozole Compared to Placebo in Patients Completing Five Years of Hormonal Therapy Consisting of an Aromatase Inhibitor (AI) or Tamoxifen Followed by an AI in Prolonging Disease-Free Survival i
09-2020
Randomized Phase II/III Study of Nivolumab plus Ipilimumab plus Sargramostim versus Nivolumab plus Ipilimumab in Patients with Unresectable Stage III or Stage IV Melanoma
Randomized Phase II/III Study of Nivolumab plus Ipilimumab plus Sargramostim versus Nivolumab plus Ipilimumab in Patients with Unresectable Stage III or Stage IV Melanoma
04-2020
A Phase III Randomized Study of Adjuvant Ipilimumab Anti-CTLA4 Therapy versus High Dose Interferon a-2b for Resected High Risk Melanoma
A Phase III Randomized Study of Adjuvant Ipilimumab Anti-CTLA4 Therapy versus High Dose Interferon a-2b for Resected High Risk Melanoma
05-2019
Program for the Assessment of Clinical Cancer Tests (PACCT-1): Trial assigning individualized Options for Treatment: The TAILORx Trial
Program for the Assessment of Clinical Cancer Tests (PACCT-1): Trial assigning individualized Options for Treatment: The TAILORx Trial
04-2019
A Phase III Clinical Trial comparing the combination of TC plus Bevacizumab to TC alone and to TAC for Women with Node-Positive or High-Risk Node-Negative, HER2-Negative Breast Cancer
A Phase III Clinical Trial comparing the combination of TC plus Bevacizumab to TC alone and to TAC for Women with Node-Positive or High-Risk Node-Negative, HER2-Negative Breast Cancer
02-2019
A Phase 1/2 Study of SL-701, a Subcutaneously Injected Multivalent Glioma-Associated Antigen Vaccine, in Adult Patients with Recurrent Glioblastoma Multiforme
A Phase 1/2 Study of SL-701, a Subcutaneously Injected Multivalent Glioma-Associated Antigen Vaccine, in Adult Patients with Recurrent Glioblastoma Multiforme
10-2016
MK-3475-006-01
MK-3475-006-01
05-2016
A Randomized Phase II study of MK-3475 versus chemothereapy in Patients with Advanced Melanoma
A Randomized Phase II study of MK-3475 versus chemothereapy in Patients with Advanced Melanoma
02-2016
MK-3475-030-00
MK-3475-030-00
11-2015
MK-8669-064
MK-8669-064
04-2015
A5481023
A5481023
02-2015
E3805: CHAARTED: ChemoHormonal Therapy versus Androgen
E3805: CHAARTED: ChemoHormonal Therapy versus Androgen
05-2011
FB-6/VEG110264
FB-6/VEG110264
Publications
Search Google Scholar for Stephen Staal
Co-Investigator Network
David Tran
Chief, Co-Director and Professor
University of Florida
MD-NEUROSCIENCE, College-Medicine
david.tran@neurosurgery.ufl.edu
Websites
Search Google Scholar for Stephen Staal
Contact Information
stephen.staal@medicine.ufl.edu
3522737832
PO Box 100278 GAINESVILLE, FL 32610-0278
Profile QR code
What is this?
Keyword Search
Please enter valid search criteria.
Search
Centers
Experts
Projects
Speakers
Stories
Technologies
Videos
University
All Universities
Florida A&M University
Florida Atlantic University
Florida Gulf Coast University
Florida Institute of Technology
Florida International University
Florida State University
University of Central Florida
University of Florida
University of Miami
University of North Florida
University of South Florida
University of West Florida
Browse by STEM
Biotechnology
Computer Science
Energy
Engineering
Environmental Sciences
Information Science
Life Sciences
Mathematics
Medical Sciences
Military Sciences
Natural Sciences
Physical Sciences
Plant Sciences
Science
Space Sciences
Technology
Transportation
